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Background: Older age has been identified as an important risk factor after ST Elevation Myocardial Infarction (STEMI) in the thrombolytic era. 
Currently, the relationship between older age and mortality after contemporary primary percutaneous coronary intervention (pPCI) remains largely 
unexplored.
Methods: Between 1997 and 2007, we admitted 4506 STEMI patients treated with pPCI. Baseline clinical, angiographic and procedural 
information was entered in a dedicated database. Cox regression analysis was used to investigate the relation between age and one-year mortality.
Results: One-year follow-up was complete for all patients. Mean age was 61±13 years. Advancing age was correlated with an increased prevalence 
of hypertension, diabetes, a history of previous MI, cardiogenic shock, and multivessel disease. Furthermore, older patients were more often female 
and had a lower rate of post-pPCI TIMI 3 flow. Figure 1 shows the relation between age and one-year mortality. The unadjusted hazard ratio (HR) of 
age for one-year mortality was 1.050 (95% CI 1.042-1.057, p<0.01) per year increment. After adjusting for aforementioned variables the HR was 
1.037 (95% CI 1.029-1.045, p<0.01).
Conclusion: Advancing age is strongly associated with increased one-year mortality after pPCI for STEMI. After multivariate analysis, the 
relationship between age and one-year mortality somewhat weakens but remains significant. This study warrants further investigation into optimal 
STEMI treatment in the elderly.
